- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.95 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x GLC- GLC: alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose(Non-covalent)
- 26 x IOD: IODIDE ION(Non-functional Binders)
IOD.3: 1 residues within 4Å:- Chain A: V.245
Ligand excluded by PLIPIOD.4: 2 residues within 4Å:- Chain A: N.151, Y.211
Ligand excluded by PLIPIOD.5: 1 residues within 4Å:- Chain A: G.57
Ligand excluded by PLIPIOD.6: 2 residues within 4Å:- Chain A: A.169, F.259
Ligand excluded by PLIPIOD.7: 1 residues within 4Å:- Chain B: E.222
Ligand excluded by PLIPIOD.8: 1 residues within 4Å:- Chain A: K.27
Ligand excluded by PLIPIOD.9: 1 residues within 4Å:- Chain A: N.219
Ligand excluded by PLIPIOD.10: 2 residues within 4Å:- Chain A: A.363, T.367
Ligand excluded by PLIPIOD.11: 2 residues within 4Å:- Chain A: N.13, K.43
Ligand excluded by PLIPIOD.12: 3 residues within 4Å:- Chain A: N.350
- Chain B: R.355
- Ligands: IOD.25
Ligand excluded by PLIPIOD.13: 4 residues within 4Å:- Chain A: P.49, G.70, Y.71, S.74
Ligand excluded by PLIPIOD.16: 1 residues within 4Å:- Chain B: E.323
Ligand excluded by PLIPIOD.17: 2 residues within 4Å:- Chain B: P.92, F.93
Ligand excluded by PLIPIOD.18: 2 residues within 4Å:- Chain B: A.169, F.259
Ligand excluded by PLIPIOD.19: 2 residues within 4Å:- Chain B: V.245, R.317
Ligand excluded by PLIPIOD.20: 2 residues within 4Å:- Chain A: K.145, E.222
Ligand excluded by PLIPIOD.21: 3 residues within 4Å:- Chain B: N.151, D.210, Y.211
Ligand excluded by PLIPIOD.22: 1 residues within 4Å:- Chain B: G.57
Ligand excluded by PLIPIOD.23: 2 residues within 4Å:- Chain B: N.186, G.188
Ligand excluded by PLIPIOD.24: 1 residues within 4Å:- Chain B: N.174
Ligand excluded by PLIPIOD.25: 2 residues within 4Å:- Chain A: R.355
- Ligands: IOD.12
Ligand excluded by PLIPIOD.26: 1 residues within 4Å:- Chain B: N.219
Ligand excluded by PLIPIOD.27: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPIOD.28: 2 residues within 4Å:- Chain B: G.20, E.23
Ligand excluded by PLIPIOD.29: 2 residues within 4Å:- Chain B: K.203, M.205
Ligand excluded by PLIPIOD.30: 2 residues within 4Å:- Chain B: P.335, Q.336
Ligand excluded by PLIP- 2 x NI: NICKEL (II) ION(Non-covalent)
NI.14: 3 residues within 4Å:- Chain A: H.40
- Chain B: H.216, E.222
6 PLIP interactions:2 interactions with chain A, 2 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: A:H.40, A:H.40, B:H.216, B:E.222, H2O.12, H2O.12
NI.15: 3 residues within 4Å:- Chain A: H.216, E.222
- Chain B: H.40
6 PLIP interactions:2 interactions with chain B, 2 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: B:H.40, B:H.40, A:H.216, A:E.222, H2O.2, H2O.11
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Laganowsky, A. et al., An approach to crystallizing proteins by metal-mediated synthetic symmetrization. Protein Sci. (2011)
- Release Date
- 2011-09-21
- Peptides
- Maltose-binding periplasmic protein: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
C
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.95 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x GLC- GLC: alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose(Non-covalent)
- 26 x IOD: IODIDE ION(Non-functional Binders)
- 2 x NI: NICKEL (II) ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Laganowsky, A. et al., An approach to crystallizing proteins by metal-mediated synthetic symmetrization. Protein Sci. (2011)
- Release Date
- 2011-09-21
- Peptides
- Maltose-binding periplasmic protein: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
C